← Back
$RXRX All transactions

RECURSION PHARMACEUTICALS, INC.

F

$ Value

$41K

Shares

10,364

Price

$4

Filed

Feb 10

Insider

Name

Khan Najat

Title

CEO and President

CIK

0002020969

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-06

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,304,663

Footnotes

This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2026 and every three months thereafter. | This RSU vested immediately upon the grant date. | Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.

Filing Info

Accession No.

0001601830-26-000014

Form Type

4

Issuer CIK

0001601830

Khan Najat's History

Date Ticker Type Value
2026-02-17 RXRX F $50K
2026-02-06 RXRX A $0
2026-02-06 RXRX A $0
2026-02-06 RXRX F $41K
2025-12-22 RXRX $549K
2025-11-17 RXRX F $73K
2025-11-05 RXRX A $0
2025-11-05 RXRX A $0
2025-08-18 RXRX $202K
2025-08-15 RXRX F $21K

Other Insiders at RXRX (90d)

Insider Bought Sold Last
Taylor Ben R
Chief Financial Officer
$41K 2026-04-06
Li Dean Y 2026-04-01
Dar Zavain 2026-04-01
Borgeson Blake $1.6M 2026-04-07
Gibson Christopher $557K 2026-04-07
Hallett David
Chief Scientific Officer
2026-02-17
Khan Najat
CEO and President
2026-02-17